Search research articles
Contact Us
Filters
Showing results (251-260 of 302) with videos related to
Page
of 31
Sort By:
JAMA Oncology
|
April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
Rachna T Shroff, Milind M Javle, Lianchun Xiao, et al.
Annals of the Rheumatic Diseases
|
April 7, 2007
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib
M E Farkouh, J D Greenberg, R V Jeger, et al.
Molecular Cancer Therapeutics
|
July 28, 2021
Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors
Michael S Gordon, John Nemunaitis, Minal Barve, et al.
British Journal of Cancer
|
July 20, 2017
Clinical study of genomic drivers in pancreatic ductal adenocarcinoma
Michael T Barrett, Ray Deiotte, Elizabeth Lenkiewicz, et al.
The Oncologist
|
January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancer
Richard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.
Cancer Discovery
|
March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers
Johann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2017
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study
Ramesh K Ramanathan, Ronald L Korn, Natarajan Raghunand, et al.
Cancer Discovery
|
March 24, 2017
Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors
Dejan Juric, Ian Krop, Ramesh K Ramanathan, et al.
Investigational New Drugs
|
October 12, 2012
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors
Michael S Gordon, Lee S Rosen, David Mendelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers
Ramesh K Ramanathan, Donald L Trump, Julie L Eiseman, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 302) with videos related to
Sort By:
Page
of 31
JAMA Oncology
|
April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
Rachna T Shroff, Milind M Javle, Lianchun Xiao, et al.
Annals of the Rheumatic Diseases
|
April 7, 2007
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib
M E Farkouh, J D Greenberg, R V Jeger, et al.
Molecular Cancer Therapeutics
|
July 28, 2021
Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors
Michael S Gordon, John Nemunaitis, Minal Barve, et al.
British Journal of Cancer
|
July 20, 2017
Clinical study of genomic drivers in pancreatic ductal adenocarcinoma
Michael T Barrett, Ray Deiotte, Elizabeth Lenkiewicz, et al.
The Oncologist
|
January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancer
Richard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.
Cancer Discovery
|
March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers
Johann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2017
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study
Ramesh K Ramanathan, Ronald L Korn, Natarajan Raghunand, et al.
Cancer Discovery
|
March 24, 2017
Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors
Dejan Juric, Ian Krop, Ramesh K Ramanathan, et al.
Investigational New Drugs
|
October 12, 2012
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors
Michael S Gordon, Lee S Rosen, David Mendelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers
Ramesh K Ramanathan, Donald L Trump, Julie L Eiseman, et al.
Page
of 31